13-cis-Retinoic Acid
Showing 1 - 25 of >10,000
Solid Tumor Trial in San Diego (Cabozantinib, 13-cis-retinoic acid)
Recruiting
- Solid Tumor
- Cabozantinib
- 13-cis-retinoic acid
-
San Diego, CaliforniaRady Children's Hospital - San Diego
Oct 6, 2021
Male Infertility, Azoospermia Trial in Seattle (13-cis retinoic acid)
Completed
- Male Infertility, Azoospermia
- 13-cis retinoic acid
-
Seattle, WashingtonUniversity of Washington Medical Center
Sep 27, 2021
COVID19 Trial in Cairo (Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment, Isotretinoin(Aerosolized 13 cis
Not yet recruiting
- COVID19
- Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment
- +4 more
-
Cairo, Kafr El-sheikh, Egypt
- +1 more
Jul 29, 2021
Tuberculosis Trial in Cairo, Riyadh (13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB), 9 cis retinoic
Not yet recruiting
- Tuberculosis
- 13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB)
- +5 more
-
Cairo, Kafr El-sheikh, Egypt
- +1 more
Oct 11, 2021
Male Infertility, Klinefelter's Syndrome, Y-chromosome Microdeletions Trial in Seattle (13-cis retinoic acid, Calcitriol)
Completed
- Male Infertility
- +2 more
- 13-cis retinoic acid
- Calcitriol
-
Seattle, WashingtonUniversity of Washington Medical Center
Jul 29, 2021
Covid19 Vaccine Trial (drug, combination product, biological)
Not yet recruiting
- Covid19 Vaccine
- Oral 13 cis retinoic acid
- +4 more
- (no location specified)
May 28, 2021
Neuroblastoma Trial in United Kingdom (Liquid 13-Cis Retinoic Acid, Extracted capsules 13-CRA)
Completed
- Neuroblastoma
- Liquid 13-Cis Retinoic Acid
- Extracted capsules 13-CRA
-
Birmingham, United Kingdom
- +9 more
Sep 22, 2021
Breast Cancer Female Trial (All trans-retinoic acid, 13-Cis Retinoic Acid plus Tocopherol, Mifepristone)
Not yet recruiting
- Breast Cancer Female
- All trans-retinoic acid
- +6 more
- (no location specified)
Aug 17, 2021
High-risk Neuroblastoma Trial in China (Dinutuximab Beta, 13 cis retinoic acid)
Active, not recruiting
- High-risk Neuroblastoma
- Dinutuximab Beta
- 13 cis retinoic acid
-
Beijing, Beijing, China
- +3 more
Dec 7, 2022
Neuroblastoma Trial in Minneapolis (drug, biological, radiation)
Recruiting
- Neuroblastoma
- Carboplatin
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 11, 2022
Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,
Active, not recruiting
- Ganglioneuroblastoma
- High Risk Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +14 more
-
Los Angeles, California
- +9 more
Sep 1, 2022
Brain Tumors Trial in Canada, United States (temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid)
Completed
- Brain Tumors
- temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid
-
Phoenix, Arizona
- +16 more
Jun 17, 2021
Post COVID-19 Anosmia (Loss of Smell) Trial in Foshan, Kafr Ash Shaykh, Riyadh (Aerosolized 13 cis retinoic acid plus Vitamin D,
Not yet recruiting
- Post COVID-19 Anosmia (Loss of Smell)
- Aerosolized 13 cis retinoic acid plus Vitamin D
- +2 more
-
Foshan, Guangdong, China
- +2 more
Nov 9, 2021
Covid19 Trial (Aerosolized 13 cis retinoic acid plus Inhalation administration by nebulization captopril 25mg, Drug: Standard
Not yet recruiting
- Covid19
- Aerosolized 13 cis retinoic acid plus Inhalation administration by nebulization captopril 25mg
- Drug: Standard treatment Standard treatment
- (no location specified)
Oct 23, 2020
Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified Trial in United States (radiation, drug,
Completed
- Medulloblastoma
- +2 more
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Los Angeles, California
- +14 more
Jan 12, 2022
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,
Completed
- Acute Myelogenous Leukemia
- +2 more
- Fludarabine
- +5 more
-
New York, New YorkColumbia University Medical Center
Aug 4, 2021
Leukemia Trial in Chicago, Kankakee (recombinant interferon alfa, amifostine trihydrate, bromodeoxyuridine)
Withdrawn
- Leukemia
- recombinant interferon alfa
- +7 more
-
Chicago, Illinois
- +3 more
Oct 6, 2021
Covid19 Trial in Cairo (Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) plus Aerosolized Itraconazole, Drug:
Not yet recruiting
- Covid19
- Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) plus Aerosolized Itraconazole
- Drug: Isotretinoin(Aerosolized 13 cis retinoic acid)
-
Cairo, Kafr El-sheikh, EgyptKafr El-sheikh University
Oct 5, 2020
COVID Trial (Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid)
Not yet recruiting
- COVID
- Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid
- (no location specified)
Jun 5, 2021
Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Bronx, New York (vorinostat,
Terminated
- Recurrent Renal Cell Cancer
- +2 more
-
Bronx, New York
- +1 more
Feb 1, 2021
High Risk Neuroblastoma Trial in United States (biological, other, drug)
Completed
- High Risk Neuroblastoma
- Aldesleukin
- +4 more
-
Loma Linda, California
- +31 more
Jul 30, 2021
Drug Toxicity, Lung Cancer Trial in Denver (13-cis retinoic acid, Tocopherol)
Completed
- Drug Toxicity
- Lung Cancer
- 13-cis retinoic acid
- Tocopherol
-
Denver, Colorado
- +3 more
May 13, 2020
Covid19 Trial (Aerosolized 13 cis retinoic acid plus Inhalation Inhaled testosterone, The standard therapy)
Unknown status
- Covid19
- Aerosolized 13 cis retinoic acid plus Inhalation Inhaled testosterone
- The standard therapy
- (no location specified)
Nov 9, 2020
Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)
Active, not recruiting
- Ganglioneuroblastoma, Nodular
- Neuroblastoma
- Dinutuximab
- +4 more
-
Mesa, Arizona
- +77 more
Aug 17, 2022